Please assess the completion status of the following clinical trial:

Trial Title: A Research Study for Patients With Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Must be between 18-85 years old~* Must have been diagnosed by his/her doctor with overactive bladder at least 6 months ago~* Must weigh at least 50 kg (110 lbs)~* Must be willing and able to record information regarding bladder function into a diary (provided)~* Must be willing and able to complete the entire course of the study~Exclusion Criteria:~* Cannot currently be catheterizing as a way to control incontinence~* Must not have used botulinum toxin type A or any other botulinum toxin previously for any condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo (normal saline) injected into detrusor on Day 1
- BOTOX 50 U (Type: EXPERIMENTAL): botulinum toxin Type A 50 U injected into detrusor on Day 1
- BOTOX 100 U (Type: EXPERIMENTAL): botulinum toxin Type A 100 U injected into detrusor on Day 1
- BOTOX 150 U (Type: EXPERIMENTAL): botulinum toxin Type A 150 U injected into detrusor on Day 1
- BOTOX 200 U (Type: EXPERIMENTAL): botulinum toxin Type A 200 U injected into detrusor on Day 1
- BOTOX 300 U (Type: EXPERIMENTAL): botulinum toxin Type A 300 U injected into detrusor on Day 1

Based on this trial design, predict the completion outcome and termination type (if applicable).